According to the latest report by Mordor Intelligence, the ophthalmic drugs market size was valued at USD 40.58 billion in ...

HARLINGEN, Texas (ValleyCentral) — Alexa Nichols, a former ophthalmic technician and rising third year medical student at the ...

Haag-Streit USA, a leading US distributor of high-quality ophthalmic devices, has announced a new strategic initiative in collaboration with the prestigious Casey Eye Institute at Oregon Health & ...

A new study presents an artificial intelligence system that scans images of the retina to detect signs of diabetes, high ...

Two biotech innovators, two very different risk profiles: one with commercial products and another betting on next-gen gene editing breakthroughs.

Cloudbreak Pharma Inc., (HKEX 2592), a clinical stage ophthalmic drug company leveraging its proprietary Multi Kinase Inhibitor (MKI) discovery platform to develop first-in-class and best-in-class ...

Detailed price information for Precision Optics Corp Inc (POCI-Q) from The Globe and Mail including charting and trades.

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific ...

Yunara Life, a next-generation, whole-health ecosystem that sits at the intersection of lifestyle medicine, wellness, and regenerative aesthetics, is officially launching this July in New York City ...